MedTrace Logo

Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer

NCT00027768 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2013-09-20

No results posted yet for this study

Summary

RATIONALE: Radioactive iodine may be effective in reducing the rate of recurrence of liver cancer after surgery to remove the tumor. It is not yet known if radioactive iodine is more effective than no further treatment after surgery.

PURPOSE: Randomized phase III trial to determine the effectiveness of radioactive iodine in treating patients who have undergone surgery for liver cancer.

Conditions

Interventions

PROCEDURE

adjuvant therapy

RADIATION

iodine I 131 ethiodized oil

Sponsors & Collaborators

  • National Medical Research Council (NMRC), Singapore

    lead OTHER_GOV

Principal Investigators

  • London L. Ooi Peng Jin, MD · National Cancer Centre, Singapore

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT

Eligibility

Min Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-06-30

Countries

  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00027768 on ClinicalTrials.gov